GlassScriptPhysician profile
Adam Prevot
NPI 1598344970
$409.11
in general payments reported to CMS, 2019-2025
9 companies · $398 in 2025
The $398 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11.47 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ionis Pharmaceuticals, INC. | $109.23 | 2025 | Dawnzera |
| Takeda Pharmaceuticals U.S.A., INC. | $76.31 | 2025 | Hyqvia, Cuvitru |
| Novartis Pharmaceuticals Corporation | $56.97 | 2025 | |
| Csl Behring | $36.05 | 2025 | Andembry |
| Glaxosmithkline, LLC. | $33.65 | 2025 | Nucala |
| Biocryst US Sales Co., LLC | $33.50 | 2025 | Orladeyo |
| Regeneron Healthcare Solutions, INC. | $27.47 | 2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $24.46 | 2025 | Fasenra |
| Organon LLC | $11.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Prevot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.